Cosmo Bio USA Expands Product Offering with Addition of ORF Biologics Portfolio
The new offering will supply innovative, high-quality products that exceed the demands of an evolving biologics industry
We're excited to collaborate with ORF Biologics to bring their high-quality biologics and cell biology portfolio to our customers.”
CARLSBAD, CA, UNITED STATES, February 17, 2026 /EINPresswire.com/ -- Cosmo Bio USA, a leading international distributor of life science research products, announced the expansion its product offering with the addition of advanced biologics, cells, tissue culture media and ancillary research products developed by ORF Biologics, Inc.— Theresa Schaub, Division President and COO of Cosmo Bio USA
The products will be sold through Cosmo Bio USA under a non-exclusive distribution agreement into the research and therapeutic markets in US, Canada, and Asia Pacific.
The ORF Biologics portfolio advances science through the use of synthetic biology and proprietary biologics manufacturing platforms to drive research and therapeutic breakthroughs.
"We're excited to collaborate with ORF Biologics to bring their high-quality biologics and cell biology portfolio to our customers,” said Theresa Schaub, Division President and Chief Operating Officer of Cosmo Bio USA. "We believe our partnership will give scientists the tools necessary to accelerate their work in infectious disease, neurodegeneration, regenerative medicine, oncology, wound healing and biosecurity."
"We started ORF Biologics to pioneer the production of next-generation biologics by managing the entire process from initial design to final protein delivery," said Anant Kamath, Chief Executive Officer of ORF Biologics. "Cosmo Bio shares our focus of providing innovative, high-quality products that meet and exceed the demands of a rapidly expanding and an evolving industry."
Learn more and view the ORF Biologics portfolio available through Cosmo Bio USA: https://www.cosmobiousa.com/suppliers/orf-biologics.html
About Cosmo Bio USA
Cosmo Bio USA bridges the gap between global innovation and scientific discovery by providing researchers worldwide with exclusive access to high-performance reagents and research tools from over 70 international manufacturers. Specializing in unique solutions from Japanese and select global innovators, we offer products trusted internationally for their precision and reliability—from cell-free protein expression systems to animal IVF tools and single-cell analysis technologies. With responsive technical guidance, transparent shipping, and flexible procurement options, we empower biotech, pharma, and academic teams across the United States, Canada, Europe, and Asia-Pacific to focus on breakthrough science, not logistics.
About ORF Biologics, Inc.
ORF Biologics, Inc., headquartered in Tiffin, Iowa, specializes in the expression of recombinant proteins and the development of assays for biologics research. The company is dedicated to advancing scientific discovery through innovative solutions and collaborative partnerships.
Wendy Parenteau
Cosmo Bio USA
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
